Agios Pharma (AGIO) Tops Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Join SI Premium – FREE
Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.69), $0.12 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $13.91 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean Nears Deal For Sandals - FT
- Active options: MSFT SOFI MSTR GME GRAB BAC AVGO NFLX ORCL GOOG
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
